Summary
Defibrillation is a common treatment for life-threatening cardiac dysrhythmias, ventricular fibrillation, and pulseless ventricular tachycardia. Defibrillation consists of delivering a therapeutic dose of electrical energy to the heart with a device called a defibrillator. This depolarizes a critical mass of the heart muscle, terminates the dysrhythmia, and allows normal sinus rhythm to be reestablished by the body's natural pacemaker, in the sinoatrial node of the heart. Defibrillators can be external, transvenous, or implanted (implantable cardioverter-defibrillator), depending on the type of device used or needed. Some external units, known as automated external defibrillators (AEDs), automate the diagnosis of treatable rhythms, meaning that lay responders or bystanders are able to use them successfully with little or no training at all.
Growth of the global Defibrillator market size is majorly driven by increasing prevalence of cardiovascular diseases and technological advancements.
The global defibrillator market was estimated at 13.97 Billion USD in 2021 and will reach 20.33 Billion USD in 2030 with CAGR 4.26% during 2021-2030. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
The report includes market size, upstream situation, market segmentation, price & cost, and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels. The report begins with an overview of the industrial chain structure and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment. Additionally, the report introduces market competition overview among the major companies and companies profiles; besides, market price and channel features are covered in the report.
Based on products type, the report describes major products type share of the regional market. Products mentioned as follows:
- Advanced Life Support Defibrillators (ALS)
- Automated External Defibrillator (AED)
- Implantable Cardioverter-defibrillator (ICD)
- Wearable Cardiac Defibrillator
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
- Medtronic
- Abbott
- Boston Scientific
- Biotronik
- Physio-Control
- Nihon Kohden Corporation
- Zoll Medical
- Cardiac Science
- Philips Healthcare
- PRIMEDIC
- Schiller
- Sorin Group
- HeartSine Technologies
- Defibtech
Based on Application, the report describes major application share of the regional market. Application mentioned as follows:
- Hospitals
- Emergency Care
- Home Care
- Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
- Asia-Pacific
- North America
- Europe
- South America
- Middle East & Africa
Frequently Asked Questions
What is the USP of the report? expand_more
What are the key content of the report? expand_more
- Global Market Players
- Geopolitical regions
- Consumer Insights
- Technological advancement
- Historic and Future Analysis of the Market